|
Product Feature - Kinase Inhibitors
A protein kinase is an enzyme that chemically modifies proteins by the addition of a phosphate group. This modification results in a change in the protein activity, cellular localisation or association with other proteins.
The human genome consists of roughly 500 protein kinase genes; about 2% of all eukaryotic genes. 30% of all proteins can be modified by kinases and kinases regulate the majority of cellular pathways. Disregulation of kinase activity has been implicated in diseases such as cancer and kinase inhibitors are being developed as potential therapeutics.
Cell Cycle Kinase Inhibitors
ATM and ATR protein kinases are key regulators of the cell cycle checkpoint pathways in response to DNA damage. ATM responds to double stranded DNA breaks (DSBs) whilst ATR only plays a small role in DSBs and primarily responds to damage induced by UV light. Activated ATM and ATR phosphorylate and activate Chk1 and Chk2 respectively.
|
|
|
|
|
|